Walter Bordogna

Identification and optimisation of a series of substituted 5-(1H-pyrazol-3-yl)-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitors.

Steve Price, D. E. Clark, H. Dyke, 2007, Bioorganic & medicinal chemistry letters.

PTPRF Expression as a Potential Prognostic/Predictive Marker for Treatment with Erlotinib in Non–Small-Cell Lung Cancer

Paul Delmar, F. Hirsch, F. Shepherd, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.